Skip to Content Skip to Search
Researchers collaborating in an office

Our research areas of focus

GSK currently has 14 oncology assets in clinical development, and we are pleased to be sharing presentations at ASH that have the potential to demonstrate meaningful improvements in outcomes for patients.

As a leader in oncology research and development, we have advanced our innovative pipeline by focusing on science related to the immune system, the use of human genetics and cutting-edge technologies that will advance the next wave of cancer therapies.

 

Oncology research areas

Learn more about our research areas focused on science related to the immune system, the use of human genetics and cutting-edge technologies that could advance the next wave of cancer therapies.